Wang, X. (2020) “Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis: Abiraterone versus enzalutamide in mCRPC”, Journal of Pharmacy & Pharmaceutical Sciences, 23, pp. 451–461. doi: 10.18433/jpps31003.